Recently, MELK has been defined as a crucial oncogene that plays indispensable roles in the Akt/mTOR signaling pathway to mediate the progression of colorectal cancer (CRC) (Tang et al. 2022). The gene discussed is MTOR; the disease is colorectal carcinoma.